{
    "code": 0,
    "data": [
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration Of Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the unaudited consolidated and standalone financial results of the Company for the quarter and nine months ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3aeb6e8b-abb9-4e3b-9d5e-7c50a5022ed0.pdf",
            "news_date": "2026-02-04 15:49:11"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance- Certificate under Reg 74 (5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=555161fd-55fd-4f02-bc54-b8093487e75c.pdf",
            "news_date": "2026-01-16 12:37:26"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)- EU Approval For Product Registration Of Paracetamol",
            "news_body": "Announcement under Regulation 30 (LODR) - EU approval for product registration of Paracetamol from Danish Medicine Authority with XGX Pharma - Denmark",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03a5b43b-0110-42e1-b417-6b7a08c5bf91.pdf",
            "news_date": "2026-01-07 15:59:01"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window - For declaration of unaudited financial results for the quarter ended on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67893125-c38f-4550-b0e9-2d40998d146b.pdf",
            "news_date": "2025-12-26 12:39:26"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Announcement under Regulation 30 (LODR) - Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=830064e7-2fa2-433b-b6c9-75b086654672.pdf",
            "news_date": "2025-11-18 16:06:06"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended On September 30 2025",
            "news_body": "Financial Results for the quarter and half year ended on September 30 2025",
            "news_id": "22459a21-c458-4813-a21c-ef741aa32c05",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0c4c856-770e-411d-a02b-99f047bc1988.pdf",
            "news_date": "2025-11-14 16:22:32",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended On September 30 2025",
            "news_body": "Financial Results for the quarter and half year ended on September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0c4c856-770e-411d-a02b-99f047bc1988.pdf",
            "news_date": "2025-11-14 16:22:32"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration Of Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter And Half Year Ended On September 30 2025",
            "news_body": "Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve unaudited Financial Results of the Company for the quarter and half year ended on September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82ee6677-df13-4a51-8795-efff2cd7a48c.pdf",
            "news_date": "2025-11-05 16:37:16"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance - Certificate under Regulation 74 (5) of SEBI (DP) Regulation 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59b0bf88-5d64-4440-b11d-2438d362b6e6.pdf",
            "news_date": "2025-10-25 17:21:36"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Clsoure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e8b6b65-9403-4a0e-a765-adc08019ceec.pdf",
            "news_date": "2025-09-27 17:33:31"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Voting Results of the 32nd AGM along with the consolidated Scrutinizer Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d981de4-1144-4fd7-89ef-ac9bca0cfb64.pdf",
            "news_date": "2025-09-27 16:25:55"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Outcome of the 32nd Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3602eb11-a277-48f5-b472-7570271da4d0.pdf",
            "news_date": "2025-09-26 14:41:20"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Revised Intimation Of Book Closure In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
            "news_body": "Please find enclosed herewith the revised intimation for Book Closure for the purpose of 32nd Annual general Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e56cefd-bf9f-4fa4-988b-e0ef0f91079e.pdf",
            "news_date": "2025-09-04 17:15:22"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Book Closure In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
            "news_body": "Please find enclosed herewith the intimation for Book Closure for the purpose of the 32nd Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e1d05d7-2f7a-4553-8bf2-d91fc34174c5.pdf",
            "news_date": "2025-09-04 11:38:23"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) please find enclosed the Notice convening the 32nd AGM and the Annual Report of the Company including Business Responsibility and Sustainability Report for the financial year 2024-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e1f2b18-53f0-4664-ade6-bf2694e1bee5.pdf",
            "news_date": "2025-09-03 18:28:11"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Announcement under Regulation 30 (LODR) - Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cd2dc0a-13cb-44a2-9ea9-887bd0151719.pdf",
            "news_date": "2025-08-13 13:52:06"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Announcement under Regulation 30 (LODR) - Change in management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65af94e3-b6db-40e2-8103-4999a9e53f4c.pdf",
            "news_date": "2025-08-12 18:36:33"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report - 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb0a4e08-dce5-4b97-905e-1686b0f46f1c.pdf",
            "news_date": "2025-08-12 18:34:10"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On August 12 2025",
            "news_body": "Outcome of the Board meeting held on August 12 2025",
            "news_id": "ab3e037e-b32e-4cec-8833-f668f3e18d8f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de7ad267-697d-4993-9a6d-a36203b72348.pdf",
            "news_date": "2025-08-12 16:35:18",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On August 12 2025",
            "news_body": "Outcome of the Board meeting held on August 12 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de7ad267-697d-4993-9a6d-a36203b72348.pdf",
            "news_date": "2025-08-12 16:35:18"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for For Consideration And Approval Of Unaudited Financial Results For The Quarter Ended On June 30 2025.",
            "news_body": "Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve unaudited (Standalone and Consolidated) financial results for the quarter ended on June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c386c543-9da9-473d-bb98-0f38b0a35e55.pdf",
            "news_date": "2025-08-07 16:30:12"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance - Certificate under Reg 74 (5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a75f7c2-7d59-4d8d-885d-18293ce1f9c0.pdf",
            "news_date": "2025-07-29 17:21:54"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ca97437-c619-475b-a196-e063277764bd.pdf",
            "news_date": "2025-06-30 16:12:23"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)- Approval Of Abbreviated New Drug Application (ANDA)",
            "news_body": "Announcement under Regulation 30 (LODR) - Approval of Abbreviated New Drug Application (ANDA)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=502f56c9-00c4-4da3-ad9c-0e100d937a67.pdf",
            "news_date": "2025-06-03 12:51:55"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of Audited Financial Results for the quarter and year ended on March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed409b40-5825-4f69-8136-666a0ff8ae05.pdf",
            "news_date": "2025-06-02 11:49:41"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Compliance - Reg 24 (A)- Annual Secretarial Compliance Report - March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4aea42ab-2cd7-453a-86cf-2f70496a2502.pdf",
            "news_date": "2025-05-30 21:11:34"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results Year Ended On 31.03.2025",
            "news_body": "Financial Results year ended on 31.03.2025",
            "news_id": "0af10f60-d773-4721-8e62-6971529e5be3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb23b4e8-b561-4020-9894-d1e15ffee50a.pdf",
            "news_date": "2025-05-30 21:02:16",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results Year Ended On 31.03.2025",
            "news_body": "Financial Results year ended on 31.03.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb23b4e8-b561-4020-9894-d1e15ffee50a.pdf",
            "news_date": "2025-05-30 21:02:16"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulation 2015 (Listing Regulations)",
            "news_body": "Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve Medicamen Biotech Limited has informed that meeting of the Board of Directors of the Company is scheduled on 30.05.2025 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended on 31.03.2025 and to consider recommending payment of dividend to the shareholders.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1166fcdd-57b3-47b3-b466-d68d9a73fa22.pdf",
            "news_date": "2025-05-22 16:55:33"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shivalik Rasayan Ltd & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53D6638A_4A7F_4C36_94D2_5BF3B6B2C14F_151938.pdf",
            "news_date": "2025-04-28 15:19:43"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Corrigendun To The Outcome Of The Board Meeting - April 24 2025",
            "news_body": "Corrigendum to the Outcome of the meeting of the Board Meeting of Board of Directors of Medicamen Biotech Limited (\"the Company\") in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1f75fd0-1606-4ca4-9076-8f1f60372438.pdf",
            "news_date": "2025-04-25 17:58:26"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Outcome",
            "descriptor": "Revision of outcome",
            "caption": "Board Meeting Outcome for Revised Outcome Of Board Meeting 24.04.2025",
            "news_body": "Revised outcome of Board Meeting - 24.04.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0015638-799d-4b04-9c61-b2d049fcf60b.pdf",
            "news_date": "2025-04-25 16:32:37"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Outcome",
            "descriptor": "Revision of outcome",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting - April 24 2025 (Allotment Of Securities)",
            "news_body": "Outcome of Board Meeting - April 24 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af8d180f-bea0-4c81-b0a8-4802fdac6fe7.pdf",
            "news_date": "2025-04-25 12:30:29"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Of Medicamen Biotech Limited In Accordance With Regulation 30 Of SEBI (LODR) Regulation 2015- Allotment Of Equity Shares & Fully Convertible Warrants",
            "news_body": "We wish to inform you that the Board of Directors of the Company at their meeting held today i.e Thursday April 24 2025 has inter alia considered and approved the following :\r\n\r\n1. Allotment of 848220 Equity Shares\r\n2.Allotment of 650000 fully convertible warrants",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=824acd48-dde5-468c-92f3-370a82344f3b.pdf",
            "news_date": "2025-04-24 19:33:01"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 75 (5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9bda63d-7047-4fb1-bebf-73b2eee6110b.pdf",
            "news_date": "2025-04-23 12:29:50"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 31(4) Of The Securities And Exchange Board Of India (Substantial Acquistion Of Shares And Takeovers) Regulation 2011 For The Financial Year Ended On March 31 2025",
            "news_body": "Please find attached disclosure under Regulation 31(4) of SEBI (SAST) Regulation 2011",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64c3a1c7-b046-43a8-b2a6-93b17c360a94.pdf",
            "news_date": "2025-04-08 17:03:59"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) - Updates",
            "news_body": "Announcement under Regulation 30 (LODR)- Updates",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecac09a6-072c-4116-9017-d4a14a0a00b2.pdf",
            "news_date": "2025-04-08 13:13:03"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcment Under Regulation 30 (LODR)- Update",
            "news_body": "Announcement under Regulation 30 (LODR) - Update",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c09d02d4-8489-45e5-8b93-04507179c3b5.pdf",
            "news_date": "2025-04-03 12:06:28"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6751ffba-d7ef-44ed-878a-81ca56224ae0.pdf",
            "news_date": "2025-03-31 12:49:50"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Outcome",
            "descriptor": "EGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Scrutinizers Report and Voting Result under Regulation 44 of the SEBI (Listing obligation and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26442267-f79f-4620-955d-6de04572b89a.pdf",
            "news_date": "2025-03-28 17:34:12"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)- Expansion Into Regulated Markets And Long Term Vision",
            "news_body": "Announcement under Regulation 30 (LODR) - Expansion into Regulated market and Long Term Vision",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=201f57c3-04a6-4d5a-86d4-8e8b76084c97.pdf",
            "news_date": "2025-03-28 12:54:42"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Outcome",
            "descriptor": "EGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
            "news_body": "Proceedings of Extra Ordinary General Meeting of the Shareholders of the Company held on Wednesday March 26 2025 at 12:00 PM and concluded at 12:45 PM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02f4b559-f2fa-4e63-b99a-ab105c413abd.pdf",
            "news_date": "2025-03-26 15:37:15"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Trading Plan under SEBI (PIT) Regulations 2015",
            "caption": "Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 2015",
            "news_body": "Intimation received from Shivalik Rasayan Limited for purchase of 21000 Equity Shares from the open market.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4699e30-51cf-48c6-b432-e3037b152211.pdf",
            "news_date": "2025-03-22 12:37:58"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "EGM",
            "caption": "Corrigendum-Notice Of The Extra Ordinary General Meeting Scheduled To Be Held On Wednesday March 26 2025 At 12:00 Noon Through Video Conferencing (\"VC\")/ Other Audio-Visuals Means (\"OAVM\")",
            "news_body": "A corrigendum has been issued to inform the Shareholders of the Company of the changes in explanatory statement as set out for Item No 1 & 2 contained in the EGM notice. The same is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a2a20d7-47d9-47b2-9627-621cea745387.pdf",
            "news_date": "2025-03-20 17:26:52"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) - Updates",
            "news_body": "Announcement under Regulation 30 (LODR) - Updates",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=753a153c-ba73-481a-a379-aff84a8e9714.pdf",
            "news_date": "2025-03-07 15:40:02"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Announcement under Regulation 30 (LODR) - Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c00e0707-2057-42a1-8959-117032191728.pdf",
            "news_date": "2025-03-04 11:50:51"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "EGM",
            "caption": "Notice Of Extra Ordinary General Meeting - Wednesday March 26 2025",
            "news_body": "Notice of Extra Ordinary General Meeting - Wednesday March 26 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a81eb8bd-1b83-4565-b200-b5df784ea6f1.pdf",
            "news_date": "2025-03-03 18:02:27"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) -  MBL Has Been Awarded By Honble Health Minister Of Ethiopia",
            "news_body": "MBL has been recognised and awarded as top No 1 suplier among 160 suplliers worldwide to EPSS for supply of high quality affordable and reliable medicine to reach communities across Ethiopia.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2db7c216-0c3f-446e-8661-aa2dcb6871ed.pdf",
            "news_date": "2025-02-27 14:04:53"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Issue of Securities",
            "caption": "Announcement under Regulation 30 (LODR)-Issue of Securities",
            "news_body": "Announcement under Regulation 30 (LODR)- Issue of Securities",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4fb65a2-9a64-4981-a9d7-4237d305a4ee.pdf",
            "news_date": "2025-02-26 16:19:10"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of (LODR)- Clarification On Price Movement",
            "news_body": "Clarification on Price Movement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21279765-4124-4559-9b1d-83a095ba83e2.pdf",
            "news_date": "2025-02-25 16:19:27"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Medicamen Biotech Ltd",
            "news_body": "The Exchange has sought clarification from Medicamen Biotech Ltd on February 24 2025 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-02-24 16:51:37"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Issunce Of One Or More Instruments Including Equity Shares/Convertible Securities Either By Way Of Preferential Issue/ Right Issue/QIP Or Any Other Mode.",
            "news_body": "MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/02/2025 inter alia to consider and approve We wish to inform you that a meeting of the Board of Directors is scheduled to be held on Wednesday February 26 2025 inter alia to consider and approve a proposal for raising of funds by way of issuance of one or more instruments including equity shares/convertible securities either by way of Preferential Issue/Right Issue/QIP or any other mode.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=090fe479-3ce9-4985-8a87-eae0c93eb22d.pdf",
            "news_date": "2025-02-21 16:18:34"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)- Updates (Manufacturing And Supply Agreement)",
            "news_body": "Announcement under Regulation 30 (LODR)- Updates (Manufacturing and Suppy Agreement)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=716cced0-bcab-424e-92dc-b99ec99b0d81.pdf",
            "news_date": "2025-02-19 17:07:59"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Announcement under Regulation 30 (LODR) - Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3ac18e8-d810-4b4f-9c9c-35c5a630293b.pdf",
            "news_date": "2025-02-13 12:34:49"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Mr. Chandan Kumar as Chief Financial Officer and Key Managerial Personnel of the Company w.e.f February 11 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a978c77-30e0-4960-a701-db143c75b972.pdf",
            "news_date": "2025-02-11 17:37:29"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended On 31.12.2024",
            "news_body": "Financial Results for the quarter ended on 31.12.2024.",
            "news_id": "904ed1c4-a636-410f-8db1-2887c49627e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4056b24a-a94d-4acb-bf2a-fd2723fbacfc.pdf",
            "news_date": "2025-02-11 15:53:02",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended On 31.12.2024",
            "news_body": "Financial Results for the quarter ended on 31.12.2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4056b24a-a94d-4acb-bf2a-fd2723fbacfc.pdf",
            "news_date": "2025-02-11 15:53:02"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Outcome of Board meeting held on 11.02.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e841303a-879d-4606-ba0c-2e2739766e74.pdf",
            "news_date": "2025-02-11 15:49:48"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter Ended On December 31 2024",
            "news_body": "MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve the standalone and consolidated unaudited financial results of the company for the quarter ended on Decmeber 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56167c21-b889-4597-9a94-481190f796d0.pdf",
            "news_date": "2025-02-04 17:22:26"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 75 (5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfe64f8f-8cf3-4653-8384-a9da0e1e3e56.pdf",
            "news_date": "2025-01-22 15:07:18"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Clsoure of Trading Window for the Quarter ending on December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bc4c13d-497d-448f-8e6d-2bb601d13fd1.pdf",
            "news_date": "2024-12-31 14:30:38"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Clarification On Price Movement",
            "news_body": "Clarification on Price Movement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2aa7a0c7-e721-4f90-9a96-4a5bdf93cf63.pdf",
            "news_date": "2024-12-06 17:18:43"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Medicamen Biotech Ltd",
            "news_body": "The Exchange has sought clarification from Medicamen Biotech Ltd on December 6, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2024-12-06 17:03:57"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement - IEPF",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8f9f3bb-861a-404d-95ac-ae0d1ba5f9c8.pdf",
            "news_date": "2024-12-06 16:03:04"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication - Board Meeting 14-11-2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42856510-b316-4891-9b16-45c3dc45b778.pdf",
            "news_date": "2024-11-15 13:59:02"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Investor Presentation - Q2- 2024",
            "news_body": "Investor Presentation - Q2- 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=414954a4-7ad8-4935-9840-20fc281878d1.pdf",
            "news_date": "2024-11-14 16:49:08"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On 14-11.2024",
            "news_body": "Outcome of the Board Meeting held on 14-11-2024",
            "news_id": "30c9496d-6f72-44fb-b01b-542788674023",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85b10326-d58f-4fac-9c68-bf9500f86a0b.pdf",
            "news_date": "2024-11-14 16:43:14",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On 14-11.2024",
            "news_body": "Outcome of the Board Meeting held on 14-11-2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85b10326-d58f-4fac-9c68-bf9500f86a0b.pdf",
            "news_date": "2024-11-14 16:43:14"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On September 30,2024",
            "news_body": "MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8402b4d4-3832-495b-a0be-189f868b54c6.pdf",
            "news_date": "2024-11-07 15:12:12"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "US FDA Approved The Sterile Injectable Oncology Formulation Facility At Haridwar And Establishment Inspection Report (EIR) Released",
            "news_body": "We wish to inform you that the Company has received US FDA approval for the sterile injectable Oncology Formulation facility at Haridwar.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc0c076e-be2d-401b-be04-cf2c46032fda.pdf",
            "news_date": "2024-10-25 12:44:05"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Compliance Certificate as per Reg 74(5) of DP Regulations for the quarter ended on 30.09.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe5fad63-f7ba-42e1-ab19-f81ce038a24c.pdf",
            "news_date": "2024-10-09 14:32:56"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "intimation for closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdaf623e-7ff4-4136-9d46-b9575d2e1233.pdf",
            "news_date": "2024-10-04 12:35:05"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of meeting with analyst/investor.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db50fd10-985f-4949-9854-3788f1901c2e.pdf",
            "news_date": "2024-09-27 19:26:27"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer''s Report",
            "news_body": "Voting Results and Scrutinizer Report under Regulation 44 of the SEBI (LODR) 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6cd0e60e-119e-49f3-8548-77ac17b2d45e.pdf",
            "news_date": "2024-09-27 15:54:53"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "We  hereby submit the summary of the proceedings of the 31st Annual General Meeting of the Company held on Thursday, September 26, 2024 through Video Conferencing / Other Audio Visual means which commenced at 12.00 PM (IST) and concluded at 01.00 PM (IST).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d62e75f4-d5ce-485c-bd5a-6f9dd7c43235.pdf",
            "news_date": "2024-09-26 18:48:01"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Trading Plan under SEBI (PIT) Regulations, 2015",
            "caption": "Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations, 2015",
            "news_body": "Intimation as per Regulation 7(3) of PIT Regulations.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b13f3fda-55df-4ebe-863f-47320a0a8b11.pdf",
            "news_date": "2024-09-18 14:44:25"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "EU GMP Certification Received For BHIWADI Formulation Facility Of Medicamen Biotech Limited.",
            "news_body": "EU GMP certification received for Bhiwadi Formulation facility",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec072e7c-709a-4b46-9c97-8d0c02660158.pdf",
            "news_date": "2024-09-11 16:43:29"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement for the 31st Annual General Meting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d2a7fb5-9514-477f-8501-629ada987a34.pdf",
            "news_date": "2024-09-03 14:17:56"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Corp. Action",
            "descriptor": "Book Closure",
            "caption": "Corporate Action- Book Closure Intimation",
            "news_body": "Book Closure Intimation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e8a5f65-8af6-4c7b-893b-bbd93fec9f5f.pdf",
            "news_date": "2024-09-02 10:50:57"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the Financial Year 2023-24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fc762da-d5be-47d0-a3f4-a4d8cbc1b994.pdf",
            "news_date": "2024-09-02 10:47:51"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "31St Annual General Meeting",
            "news_body": "This is to inform you that the 31st AGM of the Company will be held on 26.09.2024 through VC/ OAVM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4f74df6-d017-4b38-be0b-4e472b75e612.pdf",
            "news_date": "2024-09-02 10:43:27"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for the Quarterly Results ended on 30.06.2024 publish at Financial Express and Jansatta",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=567808d9-2711-4c25-9e4f-f17c30b26723.pdf",
            "news_date": "2024-08-14 12:14:44"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report for the Financial Year 2023-24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfc8bd85-1c67-40d2-9289-b6e8cce85809.pdf",
            "news_date": "2024-08-13 15:23:00"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2024, were approved by the Board of Directors of the Company at its meeting held today at 2:00 P.M. and concluded at 03:00 P.M",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84f46ba3-fbfa-4371-9d35-65cefdf2ea0c.pdf",
            "news_date": "2024-08-13 15:21:11"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended On 30.06.2024",
            "news_body": "Financial Results for the quarter ended on 30.06.2024",
            "news_id": "94b85a43-b71d-4f8b-aafa-04d792c7f09e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6524a73d-b235-42c1-81d0-e5a50cebe878.pdf",
            "news_date": "2024-08-13 15:18:44",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended On 30.06.2024",
            "news_body": "Financial Results for the quarter ended on 30.06.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6524a73d-b235-42c1-81d0-e5a50cebe878.pdf",
            "news_date": "2024-08-13 15:18:44"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for The Approval Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On June 30, 2024 And For Approval Of Draft Financial Results For The FY 2023-24",
            "news_body": "MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve Un-audited Financial Results (Standalone & Consolidated) for the quarter ended on June 30, 2024 and for draft Annual Report for the FY 2023-24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13606800-849d-4a70-8b37-83ae8ee9d516.pdf",
            "news_date": "2024-08-07 16:00:44"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Resignation of Chief Financial Officer (CFO)",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)",
            "news_body": "Intimation of Resignation of CFO",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=502f226f-8aa0-4f59-b2a0-4e68cd49e400.pdf",
            "news_date": "2024-07-25 16:47:55"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Certificate under Regulation 74(5) of DP Regulations for the quarter ended on 30.06.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cb90e72-3763-4e14-8404-8bce05e996b2.pdf",
            "news_date": "2024-07-11 11:07:38"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window Closure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c33830e-76ad-4e0a-af11-b4bb2f87f855.pdf",
            "news_date": "2024-06-27 12:00:05"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Loss of Share Certificates",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14a60fcd-a25e-4eba-8709-42af05bf0040.pdf",
            "news_date": "2024-06-05 10:50:49"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of LODR",
            "news_body": "Completion of EU GMP Inspection at the Bhiwadi Formulation Facility of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2651957-465e-4f77-ab5b-78154ea285e7.pdf",
            "news_date": "2024-05-31 12:04:01"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for the quarter and year ended Financial results on 31.03.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de20fda9-a814-47ed-a8e1-aabdcfde7349.pdf",
            "news_date": "2024-05-31 11:57:51"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual secretarial Compliance Report as on 31.03.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec83dcf5-b1f8-40b5-b32f-69d4a153f66a.pdf",
            "news_date": "2024-05-29 20:36:32"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Reg. 32 (1), (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation",
            "news_body": "Statement of Deviation for the quarter ended on 31.03.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88e26c19-da51-414e-b813-b1f2c1568bcc.pdf",
            "news_date": "2024-05-29 17:09:06"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Approval of Audited Financial Results for the quarter ended on 31.03.2024 and recommendation of Final Dividend for the FY 2023-24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97cd09ff-aa6c-4d6d-a005-5b30e6c4cc8e.pdf",
            "news_date": "2024-05-29 16:42:17"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The FY 2024",
            "news_body": "Approval of Audited Financial results for the quarter & Year ended on 31.03.2024",
            "news_id": "e8cec1f1-04b6-4272-a2c2-4a3eb126179f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4408bdde-2f78-4f4a-9ea6-d04d396398f6.pdf",
            "news_date": "2024-05-29 16:39:36",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Results For The FY 2024",
            "news_body": "Approval of Audited Financial results for the quarter & Year ended on 31.03.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4408bdde-2f78-4f4a-9ea6-d04d396398f6.pdf",
            "news_date": "2024-05-29 16:39:36"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Audited Financial Results (Standalone & Consolidated) For The Quarter And Yearly Ended On 31.03.204",
            "news_body": "MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve Audited Financial Results (Standalone & Consolidated) for the quarter & year ended on 31.03.2024 and to approve Final Dividend for the FY 2023-24.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0d9d59f-9bcb-43ab-a685-39845aedb5cd.pdf",
            "news_date": "2024-05-21 15:34:19"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI LODR Regulations, 2015",
            "news_body": "Completion of USFDA Inspection at the Oncology Formulation Facility at Haridwar-Unit II",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3ba8ef4-ebc5-41c5-9e9e-492935cdccc3.pdf",
            "news_date": "2024-04-26 16:14:05"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Declaration Under Regulation 31 (4) Of The Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 For The Financial Year Ended On March 31, 2024.",
            "news_body": "Declaration under Regulation 31 (4) of the Securities and Exchange Board of India ( Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ended on March 31, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83bd8f4e-f939-4e3f-a52e-d6495573c9d9.pdf",
            "news_date": "2024-04-24 16:51:16"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Reg. 40 (10) - PCS Certificate for Transfer / Transmission / Transposition",
            "caption": "Certificate Pursuant To Regulation 40(9) Of The SEBI (LODR) Regulations, 2015",
            "news_body": "Certificate pursuant to Regulation 40 (9) of the SEBI (LODR) Regulations, 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37f8a6fb-3c77-442d-8a4b-989e9736cf7a.pdf",
            "news_date": "2024-04-17 16:16:37"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Reg. 7(3) \u2013 Compliance Certificate (RTA & Compliance Officer)",
            "caption": "Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, 2015 For The Financial Year Ended On March 31, 2024",
            "news_body": "Compliance certificate under Regulation 7 (3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 for the financial year ended as on March 31, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7331d348-54d9-4c49-8cd1-797ae770bcb0.pdf",
            "news_date": "2024-04-17 16:10:52"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter and year ended on March 31, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c469b003-1e60-42bf-a9e7-1c695983ee33.pdf",
            "news_date": "2024-04-17 15:58:54"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a54efc2-752d-44a5-bf21-49830eb3e86c.pdf",
            "news_date": "2024-04-01 13:03:48"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "Trading Plan under SEBI (PIT) Regulations, 2015",
            "caption": "Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations, 2015",
            "news_body": "Intimation as per Regulation 7 (3) of the SEBI (Prohibition of Insider Trading) Regulations, 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40ace49d-8c61-4409-9909-7e7afdea6d4e.pdf",
            "news_date": "2024-03-26 16:29:04"
        },
        {
            "co_code": 5905,
            "bse_code": 531146,
            "isin": "INE646B01010",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform that, Ethiopian FDA has conducted audit of Oncology Plant, Haridwar. We are awaiting the plant approval from FDA.Meanwhile we have submitted dossiers for 10 oncology products in Ethiopia. Kindly take the same on your record and oblige.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a6aeadd-5068-4a19-90e1-53fa5502e5d6.pdf",
            "news_date": "2024-03-26 11:09:43"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2023",
            "news_body": "Unaudited Financial Results for the Quarter and Nine months ended on December 31, 2023",
            "news_id": "122a0ac7-0b75-4de4-aec6-3a14f6e6bb20",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecebff43-8a38-4589-9da5-ed3f564bb082.pdf",
            "news_date": "2024-02-12 16:00:36",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results- Quarter And Half Year Ended September 30, 2023",
            "news_body": "Un-audited Financial Results- Quarter and half year ended September 30, 2023",
            "news_id": "e33a9f2b-0a6f-4022-ac6b-2b1391d0e4fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ee1c89d-1fbe-4bf9-8b2e-27389a843adb.pdf",
            "news_date": "2023-11-10 16:20:41",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On August 08, 2023",
            "news_body": "This is to inform you that the Board of Directors of the Company in its meeting held today i.e August 08, 2023, which commenced at 12.30 pm and concluded at 02.15 pm inter alia considered and approved the unaudited financial results of the company for the quarter ended on June 30, 2023.",
            "news_id": "2b3b29a3-2326-4b6a-884c-a65e7b679b48",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41377633-cec2-4b2f-8336-57402c976618.pdf",
            "news_date": "2023-08-08 14:27:06",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Year Ended March 31, 2023",
            "news_body": "We wish to inform that the Board of Directors of the Company in its meeting held today i.e. May 29, 2023, which commenced at 02.30 p.m. and concluded at 04.00 p.m., inter alia, considered and approved the Audited Standalone & Consolidated Financial Results of the Company for year ended March 31, 2023 , further details attached.",
            "news_id": "2362ecaa-ffa5-4d56-bd22-7c5bec9eca91",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=758dc12a-ed28-4d32-9563-3600d12f3601.pdf",
            "news_date": "2023-05-29 16:18:25",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Period Ended On 31St December 2022.",
            "news_body": "Financial Results For The Quarter And Nine Months Period Ended On 31st December 2022.",
            "news_id": "25d8a11f-86ee-4674-aa96-e32533bf8426",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c3afaae-1ebe-41e2-9cd3-401fbc413d65.pdf",
            "news_date": "2023-02-10 17:49:32",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results For The Quarter And Nine Months Period Ended On 31St December 2022.",
            "news_body": "We wish to inform you that the Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended on December 31, 2022.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following:<BR> <BR> a) Statement showing the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended on December 31, 2022 as Annexure-A and<BR> <BR> b) Limited Review Report from Rai Qimat & Associates, Chartered Accountants on the Un- Audited Financial Results (Standalone & Consolidated) as Annexure-B<BR> <BR> c) An Investor Presentation of the company is enclosed as Annexure-C<BR> <BR> The meeting of the Board of Directors commenced on 02.30 p.m. and concluded at 03.30 p.m.<BR> <BR>",
            "news_id": "0f4af413-4793-411e-b7cf-ab135652d3e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c29ab401-d295-4a96-b841-ef15a4557842.pdf",
            "news_date": "2023-02-10 15:41:00",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith details of related party transactions on consolidated basis for the half year ended on September 30, 2022.You are requested to take the same on record.",
            "news_id": "4b608136-ae88-44c4-ace6-6df02d022dbe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c91b7cb-5785-4b6f-b84b-9091a720d554.pdf",
            "news_date": "2022-11-23 14:11:59",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended On September 30, 2022",
            "news_body": "We wish to inform you that the Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended on September 30, 2022.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following:<BR> <BR> a) Statement showing the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended on September 30, 2022 as Annexure-A and<BR> b) Limited Review Report from Rai Qimat & Associates, Chartered Accountants on the Un- Audited Financial Results (Standalone & Consolidated) as Annexure-B<BR> c) An Investor release on the financial results is enclosed as Annexure-C<BR> <BR> The meeting of the Board of Directors commenced on 02.30 p.m. and concluded at 03.30 p.m.",
            "news_id": "4be5002e-e379-41ae-83c6-441e965a25a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70e78eb5-18d2-4b20-8042-c3171c3ffea9.pdf",
            "news_date": "2022-11-11 15:41:34",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended June 30, 2022",
            "news_body": "This is to inform that the Unaudited Standalone and Consolidated Financial Results of the Company for the<BR> quarter ended June 30, 2022 were approved by the Board of Directors of the Company at its meeting held today i.e. August 10, 2022. Further details attached.",
            "news_id": "b83287f8-2ad5-4b10-a949-bbaadd9cec74",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06f6b84b-dba7-4af2-b670-5e98efb62197.pdf",
            "news_date": "2022-08-10 15:46:18",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulations 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith details of related party transactions on consolidated basis for the half year ended on March 31, 2022.You are requested to take the same on record.",
            "news_id": "9e58b86e-0329-4eb4-aa75-c708fc3893e0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfd49845-a968-430a-bec0-1790b4c95479.pdf",
            "news_date": "2022-06-07 12:23:11",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 25.05.2022",
            "news_body": "We wish to inform you that the Board of Directors of the Company at its meeting held today approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended on March 31, 2022.<BR> we enclose the following:<BR> <BR> a) Statement showing the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended on March 31, 2022 as Annexure-A and<BR> b) Statutory Audit Report on the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended on March 31, 2022 as Annexure-B<BR> c) An Investor release on the financial results is enclose as Annexure-C<BR> <BR> Further Board of Directors at their meeting held today recommended a final dividend @ 10% on Equity Shares of Rs. 10/- each i.e. Re 1/- per Equity Share for the Financial Year 2021-22.<BR> <BR> This is for your information and records.<BR>",
            "news_id": "d06854c8-0fe4-42aa-a9d3-b3667fad2ec4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4967ac31-211d-427b-944b-aae5e4a053c3.pdf",
            "news_date": "2022-05-25 16:23:05",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting. - Financial Results",
            "news_body": "Approval of Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine Months ended on 31 December 2021.",
            "news_id": "7e2e807c-1928-4774-882d-bc78099aa56e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c2bfd07-5445-44dd-bab1-d5ff6e66210a.pdf",
            "news_date": "2022-02-08 15:51:41",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transaction",
            "news_body": "Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "9e6f77d5-e102-4ff8-ac2f-2ee825984f25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff12db2e-9eec-4c72-8ef0-44e2d8d99cad.pdf",
            "news_date": "2021-11-08 11:49:08",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On 03.11.2021",
            "news_body": "Outcome of the Board meeting held on 03.11.2021",
            "news_id": "00c33272-e4b2-4ea3-9074-e7be38a88281",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc5dccc3-f36d-40f1-9b7b-af1c54b11bc9.pdf",
            "news_date": "2021-11-03 14:56:13",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Financial Results For The Quarter Ended On June 30, 2021",
            "news_body": "The Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30, 2021.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following:<BR> <BR> a) Statement showing the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended on June 30, 2021 as Annexure-A and<BR> <BR> b) Limited Review Report from Rai Qimat & Associates, Chartered Accountants on the Un- Audited Financial Results (Standalone & Consolidated) as Annexure-B<BR> <BR> This is for your information and records.",
            "news_id": "6ca0cd1f-21ed-4eb5-a319-df7f95424d62",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9f20ffa-554a-4470-9a37-104f48852f1c.pdf",
            "news_date": "2021-08-13 17:31:39",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended June 30, 2021",
            "news_body": "The Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30, 2021.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following:<BR> <BR> a) Statement showing the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended on June 30, 2021 as Annexure-A and<BR> <BR> b) Limited Review Report from Rai Qimat & Associates, Chartered Accountants on the Un- Audited Financial Results (Standalone & Consolidated) as Annexure-B<BR> <BR> This is for your information and records.<BR>",
            "news_id": "41e61b96-d493-48bf-aecf-ba00d9ba7752",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea60eea1-e3b7-47a9-b340-de42b752111e.pdf",
            "news_date": "2021-08-13 16:13:18",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Half Year Ended On March 31, 2021.<BR> <BR>",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith details of related party transactions on consolidated basis for the half year ended on March 31, 2021.<BR> <BR> You are requested to take the same on record.<BR>",
            "news_id": "bb4385fa-945d-4c64-9fa5-e5f40266cc63",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c9c7ccb-0c5f-4264-be09-73728de8dd3c.pdf",
            "news_date": "2021-06-26 16:10:33",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results For The Quarter / Year Ended March 31, 2021",
            "news_body": "Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we enclose the following:<BR> a) Statement showing the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended on March 31, 2021 as Annexure-A and<BR> b) Audit Report on the Audited Financial Results (Standalone & Consolidated) as Annexure-B<BR> <BR> Further Board of Directors at their meeting approved the following resolutions:<BR> c) Recommended a final dividend @ 10% on Equity Shares of Rs. 10/- each i.e. Re 1/- per Equity Share for the Financial Year 2020-21.<BR> d) Appointment of M/s SPB & Co as Cost Auditor of the Company for the FY 2021-22.<BR> e) Appointment of M/s Cheena & Associates as Internal Auditor of the Company for the FY 2021-22.<BR> f) Appointment of M/s AMJ & Associates as Secretarial Auditor of the Company for the FY 2021-22.<BR> g) Adoption of New Set of MOA and AOA of the Company as per Companies Act 2013, subject to approval of shareholders in the ensuing AGM.<BR> <BR>",
            "news_id": "46330074-2d59-41bf-b8f7-fa318fc1a7a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c60d06ae-056f-47f0-9bc2-2b0dbb754826.pdf",
            "news_date": "2021-06-26 14:25:29",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MEDICAMEQ",
            "disp": "Medicamen Biotech",
            "bse_code": 531146,
            "isin": "INE646B01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Consolidated And Standalone Un-Audited Financial Results For The Quarter / Nine Months Ended December 31, 2020",
            "news_body": "Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following:<BR> <BR> a)   Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended on 31.12.2020 duly reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company  <BR> <BR> b) Limited Review Report on the Un- Audited Financial Results (Standalone & Consolidated) <BR> <BR> c) The agreement dated 17.09.2019 which was entered between Medicamen Biotech Limited and Baxyran Healthcare Private Limited has been revoked, mutually decided by the parties and as a result Medicamen Biotech Limited shall remain 100% Shareholder of the Opal Pharmaceuticals Pty Ltd.<BR> <BR> d) Our state of art US FDA compliant Oncology Plant at Haridwar shall start taking plant validations of Oncology products from 24.02.2021.<BR> <BR> The meeting of the Board of Directors commenced at 02:00 p.m. and concluded at 03:15 p.m.<BR>",
            "news_id": "c46e9ac7-669b-47bd-8e33-6e37630552af",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=447f41f7-5835-4760-997c-eb2c03978af8.pdf",
            "news_date": "2021-02-12 15:35:41",
            "seo": "medicamen-biotech-ltd",
            "ltp": 344.6,
            "ch": -13.799999999999955,
            "pch": -3.8504464285714164,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 6278,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}